Skip to main content

Magellan Biosciences Acquires TekCel for Undisclosed Amount

NEW YORK, May 16 (GenomeWeb News) - Magellan Biosciences, based in Chelmsford, Mass., has acquired Hopkinton, Mass.-based TekCel for an undisclosed amount, the company said today.

 

Magellan provides instruments and consumables for biomedical research and clinical diagnostics. TekCel provides automated sample management and assay automation systems.

 

According to Magellan, TekCell employs approximately 35 people, all of whom are expected to remain with the company.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.